Patrick Finn Horve

Experience

  1. 2021 – 2027

    Ph.D. Candidate, NIH F31 Fellow

    Guillemin Lab, Institute of Molecular Biology, University of Oregon

    Using genetic and pharmacological manipulation, live super-resolution imaging, scRNA-seq, and mitochondrial respirometry in zebrafish, ex vivo neonatal mouse islets, and cultured cells, I found that Beta-cell Expansion Factor A (BefA) permeabilizes β-cell membranes, drives calcium flux, and promotes mitochondrial function, resulting in β-cell proliferation and improved metabolic potential.

  2. 2019 – 2021

    Research Assistant

    Biology and the Built Environment Center, University of Oregon

    Led design, data collection, and analysis for a Thermo Fisher Scientific partnership that carried a prototype air sampler through five phases of Design-of-Experiments validation to commercial release as the AerosolSense sampler. Extended its validated range to influenza A, influenza B, and RSV, and ran a longitudinal human-subjects study of COVID-19-positive individuals through isolation. The university licensed the IP to Thermo Fisher with me as a named contributor.

  3. 2019 – 2020

    Research Technician

    Westerfield Lab, Institute of Neuroscience, University of Oregon

    Generated CRISPR/Cas9 knockout and knock-in zebrafish carrying patient alleles for the NIH Undiagnosed Diseases Network, modeling Usher syndrome and inherited sensory disease to test whether suspect variants cause disease.

  4. 2018 – 2019

    Undergraduate Research Assistant

    Biology and the Built Environment Center, University of Oregon

    Designed and led a hospital sampling campaign (several hundred swabs in under an hour), ran extraction, qPCR, and 16S library prep, and led the first-author paper showing room microbes track building layout and foot traffic, not window components.

Education

  1. 2027

    Ph.D., Molecular Biology

    University of Oregon · Advisor: Karen Guillemin, Ph.D. · Advanced to candidacy February 2023 · Expected June 2027

  2. 2019

    B.S., Biology

    University of Oregon · Molecular, Cellular, and Developmental Biology; minors in Chemistry and Music

Fellowships & awards

  1. 2025–2027
    NIH Ruth L. Kirschstein NRSA F31 Predoctoral Fellowship, NIDDK (F31DK141197)
  2. 2026
    Pete von Hippel Graduate Scholar Award, Institute of Molecular Biology
  3. 2025
    Knight Campus Graduate Mentor, Phil and Penny Knight Campus for Accelerating Scientific Impact
  4. 2025
    Horizon Award (Dorothy Jones Diversity & Inclusion Achievement), Applied Microbiology International, to the Microbes and Social Equity Working Group; Board of Directors member
  5. 2024
    Best Presentations Honorable Mention, Western Region Islet Study Group
  6. 2024
    Diabetes Research Connection research funding (declined in favor of the NIH F31)
  7. 2022–2024
    NIH T32 Genetics Training Program appointment, University of Oregon
  8. 2023
    Raymond-Stevens Technical Skills Training Travel Award
  9. 2022
    Borgen Adamson Memorial Scholarship, Institute of Molecular Biology
  10. 2021
    University of Oregon Innovation Award, Office of the Vice President for Research and Innovation

Grant contributions

  1. 2025

    NIH R01DK140447 (NIDDK; PI: K. Guillemin; $1.29M)

    Mechanism and therapeutic potential of BefA. Generated the preliminary data and figures.

  2. 2025

    NIH R61AT013374 (NCCIH; PI: K. Guillemin; $1.03M)

    Engineering mitohormetic probiotics; builds on mitohormesis findings from my thesis. Produced figures.

  3. 2020

    NSF #2025483, Understanding the Rules of Life ($325,000)

    Microbial response to built-environment lighting. Contributed to conception and writing.

Publications

17 peer-reviewed papers and preprints. Google Scholar · ORCID

  1. 2025
    Effects of wetting events on mass timber surface microbial communities and VOC emissions.

    Mhuireach GÁ, Collins S, Dietz L, Horve PF, et al. Frontiers in Microbiomes

  2. 2025
    Air, surface, and wastewater surveillance of SARS-CoV-2: a multimodal evaluation of COVID-19 detection in a built environment.

    Olsen Martinez A, Dietz LG, Parhizkar H, Kaya D, Northcutt D, Horve PF, et al. J Expo Sci Environ Epidemiol

  3. 2023
    Cell-type-specific responses to the microbiota across all tissues of the larval zebrafish.

    Massaquoi MS, Kong GL, Chilin-Fuentes D, Ngo JS, Horve PF, et al., Guillemin K. Cell Reports

  4. 2022
  5. 2022
  6. 2022
    Quantifying environmental mitigation of aerosol viral load in a controlled chamber with participants diagnosed with COVID-19.

    Parhizkar H, Dietz L, Olsen-Martinez A, Horve PF, et al. Clinical Infectious Diseases

  7. 2022
    Twenty important research questions in microbial exposure and social equity.

    Robinson JM, Redvers N, Camargo A, et al., Horve PF, et al., Ishaq SL. mSystems

  8. 2021
    Introducing the Microbes and Social Equity Working Group.

    Ishaq SL, Parada FJ, Wolf PG, et al., Horve PF, et al. mSystems

  9. 2021
    Evaluation of a bioaerosol sampler for indoor environmental surveillance of SARS-CoV-2.

    Horve PF, Dietz L, Northcutt D, Stenson J, Van Den Wymelenberg K. PLOS ONE

  10. 2021
    Differing effects of four building materials on viable bacterial communities and VOCs.

    Mhuireach GÁ, Dietz L, Griffiths W, Horve PF, et al. Developments in the Built Environment

  11. 2021
    Identification of SARS-CoV-2 RNA in healthcare heating, ventilation, and air conditioning units.

    Horve PF, Dietz LG, Fretz M, et al., Van Den Wymelenberg KG. Indoor Air

  12. 2021
    Exploring integrated environmental viral surveillance of indoor environments.

    Dietz L, Constant DA, Fretz M, Horve PF, et al. medRxiv preprint

  13. 2020
    SARS-CoV-2 environmental contamination and childbirth.

    Hermesch AC, Horve PF, Edelman A, et al. Obstetrics & Gynecology

  14. 2020
    Viable bacterial communities on hospital window components in patient rooms.

    Horve PF, Dietz LG, Ishaq SL, Kline J, Fretz M, Van Den Wymelenberg KG. PeerJ

  15. 2020
    2019 novel coronavirus (COVID-19) pandemic: built environment considerations to reduce transmission.

    Dietz L, Horve PF (co-first), Coil DA, Fretz M, Eisen JA, Van Den Wymelenberg K. mSystems

  16. 2020
  17. 2019

Selected talks

  1. 2024
    “Beta-cell Expansion Factor A (BefA) Promotes β-cell Proliferation and Maturation.” Selected speaker, Western Region Islet Study Group, Asilomar, CA.
  2. 2024
    “Image Segmentation with CellPose.” University of Oregon Image Analysis Workshop.
  3. 2022
    “Bacterial secreted BefA protein disrupts cellular membranes and stimulates pancreatic β-cell expansion.” ASM Northwest Branch Meeting, Spokane, WA.
  4. 2020
    “Microbiology and the Built Environment.” Yale Occupational and Environmental Medicine Guest Lecture Series (with K. Van Den Wymelenberg).

Teaching & mentoring

  1. 2026
    Course Instructor, EMBO Practical Course: Computational and Experimental Microbiomics, University of Bath
  2. 2021–2022
    Graduate Teaching Assistant, University of Oregon: Cell Biology (BI 322), Immunology and Infectious Disease (BI 326), Microbiology and Lab (BI 330/331)
  3. 2024–2026
    Research mentor to undergraduates Ella Fliesler (2025 Knight Campus Undergraduate Scholar) and Prerana Thilavalli

Memberships, service & software

  1. 2024–
    Board of Directors, Microbes and Social Equity Working Group
  2. 2022–2023
    Director of Resource Archiving, Microbes and Social Equity Working Group
  3. 2019–
    Member, Microbes and Social Equity Working Group
  4. 2018–
    Member, American Society for Microbiology
  5. Ongoing
    Peer review for PLOS ONE, mSystems, and Architectural Engineering and Design Management
  6. Software
    Author of Nucleotide_Essentials.jl, tools for DNA sequencing data in Julia